natgillin/translations-raw huggingface dataset:
It is therefore appropriate to include Ampelomyces quisqualis and Gliocladium catenulatum in Annex I, in order to ensure that in all Member States the authorisations of plant protection products containing these active substances can be granted in accordance with the provisions of that Directive.
Primerno je torej vključiti Ampelomyces quisqualis in Gliocladium catenulatum v Prilogo I zato, da se lahko v vseh državah članicah odobri registracija fitofarmacevtskih sredstev, ki vsebujejo te aktivne snovi, v skladu z določbami navedene direktive.
After inclusion of Ampelomyces quisqualis and Gliocladium catenulatum in Annex I to Directive 91/414/EEC, Member States should be allowed a reasonable period to implement the provisions of Directive 91/414/EEC as regards plant protection products containing those substances and in particular to review existing provisional authorisations and, by the end of this period at the latest, to transform those authorisations into full authorisations, to amend them or to withdraw them in accordance with the provisions of Directive 91/414/EEC.
Po vključitvi Ampelomyces quisqualis in Gliocladium catenulatum v Prilogo I k Direktivi 91/414/EGS je treba državam članicam omogočiti primeren rok za izvajanje določb Direktive 91/414/EGS glede fitofarmacevtskih sredstev, ki vsebujejo navedene snovi, ter zlasti pregledati obstoječe začasne registracije in najpozneje do izteka tega roka spremeniti te registracije v dokončne registracije, jih spremeniti ali umakniti v skladu z določbami Direktive 91/414/EGS.
It is therefore appropriate to amend Directive 91/414/EEC accordingly.
Zaradi tega je primerno Direktivo 91/414/EGS ustrezno spremeniti.
The measures provided for in this Directive are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
Ukrepi, predvideni s to direktivo, so v skladu z mnenjem Stalnega odbora za prehranjevalno verigo in zdravje živali –
Annex I to Directive 91/414/EEC is amended as set out in the Annex to this Directive.
Priloga I k Direktivi 91/414/EGS se spremeni v skladu s Prilogo k tej direktivi.
Member States shall adopt and publish by 30 September 2005 at the latest the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 30. septembra 2005.
They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.
Države članice takoj posredujejo Komisiji besedila navedenih predpisov in korelacijsko tabelo med predpisi in to direktivo.
They shall apply those provisions from 1 October 2005.
Navedene predpise uporabljajo od 1. oktobra 2005.
When Member States adopt those provisions, they shall contain a reference to this Directive or shall be accompanied by such a reference on the occasion of their official publication.
Države članice se v sprejetih predpisih sklicujejo na to direktivo ali sklic nanjo navedejo ob njihovi uradni objavi.
Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the field covered by this Directive.
Države članice Komisiji sporočijo besedilo glavnih predpisov nacionalne zakonodaje, sprejetih na področju, ki ga ureja ta direktiva.
Member States shall review the authorisation for each plant protection product containing Ampelomyces quisqualis or Gliocladium catenulatum to ensure that the conditions relating to these active substances set out in Annex I to Directive 91/414/EEC are complied with.
Države članice pregledajo registracijo za vsako fitofarmacevtsko sredstvo, ki vsebuje Ampelomyces quisqualis ali Gliocladium catenulatum, da zagotovijo izpolnjevanje pogojev v zvezi s tema aktivnima snovema, določenih v Prilogi I k Direktivi 91/414/EGS.
Where necessary, they shall amend or withdraw authorisations in accordance with Directive 91/414/EEC by 30 September 2005 at the latest.
Kjer je potrebno, registracije spremenijo ali prekličejo v skladu z Direktivo 91/414/EGS najpozneje do 30. septembra 2005.
For each authorised plant protection product containing Ampelomyces quisqualis or Gliocladium catenulatum as either the only active substance or as one of several active substances all of which were listed in Annex I to Directive 91/414/EEC by 31 March 2005 at the latest, Member States shall re-evaluate the product on the basis of a dossier satisfying the requirements of Annex III thereto.
Za vsako registrirano fitofarmacevtsko sredstvo, ki vsebuje Ampelomyces quisqualis ali Gliocladium catenulatum bodisi kot edino aktivno snov bodisi kot eno od več aktivnih snovi, ki so bile vse naštete v Prilogi I k Direktivi 91/414/EGS najpozneje do 31. marca 2005, države članice znova ocenijo sredstvo na podlagi dokumentacije, ki izpolnjuje zahteve iz Priloge III k tej direktivi.
On the basis of that evaluation, they shall determine whether the product satisfies the conditions set out in Article 4(1)(b), (c), (d) and (e) of Directive 91/414/EEC.
Na podlagi navedene ocene odločijo, ali sredstvo izpolnjuje pogoje iz člena 4(1)(b), (c), (d) in (e) Direktive 91/414/EGS.
Following that determination Member States shall:
Po tej odločitvi države članice:
in the case of a product containing Ampelomyces quisqualis or Gliocladium catenulatum as the only active substance, where necessary, amend or withdraw the authorisation by 30 September 2006 at the latest; or
če fitofarmacevtsko sredstvo vsebuje Ampelomyces quisqualis ali Gliocladium catenulatum kot edino aktivno snov, po potrebi spremenijo ali umaknejo registracijo najpozneje do 30. septembra 2006; ali
in the case of a product containing Ampelomyces quisqualis or Gliocladium catenulatum as one of several active substances, where necessary, amend or withdraw the authorisation by 30 September 2006 or by the date fixed for such an amendment or withdrawal in the respective Directive or Directives which added the relevant substance or substances to Annex I to Directive 91/414/EEC, whichever is the latest.
če fitofarmacevtsko sredstvo vsebuje Ampelomyces quisqualis ali Gliocladium catenulatum kot eno od več aktivnih snovi, po potrebi spremenijo ali umaknejo registracijo najpozneje do 30. septembra 2006 ali do datuma, določenega za tako spremembo ali umik v ustrezni direktivi ali direktivah, v katerih je bila zadevna snov ali so bile zadevne snovi dodana(-e) v Prilogo I k Direktivi 91/414/EGS, glede na to, katera je bila zadnja.
This Directive shall enter into force on 1 April 2005.
Ta direktiva začne veljati 1. aprila 2005.
Done at Brussels, 19 January 2005.
V Bruslju, 19. januarja 2005
Directive as last amended by Commission Decision 2004/99/EC (OJ L 309, 6.10.2004, p. 6).
Direktiva, kakor je bila nazadnje spremenjena z Direktivo Komisije 2004/99/ES (UL L 309, 6.10.2004, str. 6).
OJ L 239, 30.8.1997, p. 48.
UL L 239, 30.8.1997, str. 48.
OJ L 148, 15.6.1999, p. 44.
UL L 148, 15.6.1999, str. 44.
Opinion of the scientific Committee on Plants regarding the evaluation of Ampelomyces quisqualis in the context of Council Directive 91/414/EEC concerning the placing of plant protection products on the market — Opinion adopted by the Scientific Committee on Plants on 7 March 2001.
Mnenje Znanstvenega odbora za rastline o oceni Ampelomyces quisqualis v okviru Direktive Sveta 91/414/EGS o dajanju fitofarmacevtskih sredstev v promet – Mnenje je Znanstveni odbor za rastline sprejel 7. marca 2001.
In Annex I to Directive 91/414/EEC the following row is added at the end of the table:
V Prilogi I se na konec tabele dodata naslednji vrstici:
Common name, identification numbers
Splošno ime Identifikacijske številke
IUPAC Name
Ime po IUPAC
Entry into force
Datum začetka veljavnosti
Expiration of inclusion
Datum izteka vključitve
Strain: AQ 10
Soj (strain): AQ 10
Culture collection No CNCM I-807
Zbirka kulture št. CNCM I-807
CIPAC No
CIPAC št.
Not allocated
Ni dodeljena
Not applicable
Se ne uporablja
1 April 2005
april 2005
Only uses as fungicide may be authorised.
Registrira se lahko samo kot fungicid.
When granting authorisations, the conclusions of the review report on Ampelomyces quisqualis, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 8 October 2004 shall be taken into account.
Pri odobritvi registracij se upoštevajo sklepi poročila o pregledu Ampelomyces quisqualis in zlasti dodatkov I in II k poročilu, kot so bili dokončno sprejeti v Stalnem odboru za prehranjevalno verigo in zdravje živali 8. oktobra 2004.
Strain: J1446
Soj: J1446
Culture collection No DSM 9212
Zbirka kulture št. DSM 9212
When granting authorisations, the conclusions of the review report on Gliocladium catenulatum, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 30 March 2004 shall be taken into account.
Pri odobritvi registracij se upoštevajo sklepi poročila o pregledu Gliocladium catenulatum in zlasti dodatkov I in II k poročilu, kot so bili dokončno sprejeti v Stalnem odboru za prehranjevalno verigo in zdravje živali 30. marca 2004.
In this overall assessment, Member States should pay particular attention to the protection of operators and workers.
V tej celoviti oceni morajo države članice biti posebno pozorne na varovanje uporabnikov in delavcev.
Risk mitigation measures should be applied where appropriate.’
Kjer je primerno, se uporabijo ukrepi za zmanjšanje tveganja.“
Further details on identity and specification of active substances are provided in the review report.
Več podrobnosti o aktivnih snoveh in njihovih lastnostih je v poročilu o pregledu.
Commission Directive 2005/3/EC
Direktiva Komisije 2005/3/ES
amending Council Directive 91/414/EEC to include imazosulfuron, laminarin, methoxyfenozide and s-metolachlor as active substances
o spremembi Direktive Sveta 91/414/EGS zaradi vključitve imazosulfurona, laminarina, metoksifenozida in s-metolaklora na seznam aktivnih snovi
In accordance with Article 6(2) of Directive 91/414/EEC Germany received on 27 June 1996 an application from Spiess-Urania Chemicals GmbH for the inclusion of the active substance imazosulfuron in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Nemčija 27. junija 1996 prejela zahtevek od Spiess-Urania Chemicals GmbH za vključitev aktivne snovi imazosulfuron v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 97/865/EC [2] confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC.
Z Odločbo Komisije 97/865/ES [2] je bilo potrjeno, da je dokumentacija „popolna“, to je, da bi zanjo načeloma veljalo, da izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k Direktivi 91/414/EGS.
Belgium received an application under Article 6(2) of Directive 91/414/EEC on 29 March 2001 from Goëmar SA for the inclusion of the active substance laminarin in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Belgija 29. marca 2001 prejela zahtevek od Goëmar SA za vključitev aktivne snovi laminarin v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2001/861/EC [3] confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC.
Z Odločbo Komisije 2001/861/ES [3] je bilo potrjeno, da je dokumentacija „popolna“, to je, da bi zanjo načeloma veljalo, da izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k Direktivi 91/414/EGS.
The United Kingdom received an application under Article 6(2) of Directive 91/414/EEC on 21 February 2000 from Rohm and Haas France SA (now Dow AgroSciences) for the inclusion of the active substance methoxyfenozide in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Združeno kraljestvo 21. februarja 2000 prejelo zahtevek od Rohm in Haas France SA (zdaj Dow AgroSciences) za vključitev aktivne snovi metoksifenozid v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2001/385/EC [4] confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC.
Z Odločbo Komisije 2001/385/ES [4] je bilo potrjeno, da je dokumentacija „popolna“, to je, da bi zanjo načeloma veljalo, da izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k Direktivi 91/414/EGS.
Belgium received an application under Article 6(2) of Directive 91/414/EEC on 1 August 1997 from Novartis NV (now Syngenta) for the inclusion of the active substance s-metolachlor in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Belgija 1. avgusta 1997 prejela zahtevek od Novartis NV (zdaj Syngenta) za vključitev aktivne snovi s-metolaklor v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 98/512/EC [5] confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC.
Z Odločbo Komisije 1998/512/ES [5] je bilo potrjeno, da je dokumentacija „popolna“, to je, da bi zanjo načeloma veljalo, da izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k Direktivi 91/414/EGS.
For those active substances, the effects on human health and the environment have been assessed, in accordance with the provisions of Article 6(2) and (4) of Directive 91/414/EEC, for the uses proposed by the applicants.
Vplivi navedenih aktivnih snovi na zdravje ljudi in okolje so bili ocenjeni v skladu z določbami člena 6(2) in (4) Direktive 91/414/EGS za uporabe, ki so jih predlagali vlagatelji.
The designated rapporteur Member States submitted draft assessment reports concerning the substances to the Commission on 17 June 1998 (imazosulfuron), on 2 June 2003 (laminarin), on 2 August 2002 (methoxyfenozide) and 3 May 1999 (s-metolachlor).
Imenovane države članice poročevalke so Komisiji predložile osnutke poročil o oceni za te snovi 17. junija 1998 (imazosulfuron), 2. junija 2003 (laminarin), 2. avgusta 2002 (metoksifenozid) in 3. maja 1999 (s-metolaklor).
The draft assessment reports have been reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health.
Osnutke poročil o ocenah so države članice in Komisija pregledale v Stalnem odboru za prehranjevalno verigo in zdravje živali.
The review was finalised on 8 October 2004 in the format of the Commission review reports for imazosulfuron, laminarin, methoxyfenozide and s-metolachlor.
Pregled je bil končan 8. oktobra 2004 v obliki poročil Komisije o pregledu za imazosulfuron, laminarin, metoksifenozid in s-metolaklor.
For imazosulfuron, the dossier and the information from the review were also submitted to the Scientific Committee on Plants.
Za imazosulfuron so bile dokumentacija in informacije pregleda predložene tudi Znanstvenemu odboru za rastline.
The report of this Committee was formally adopted on 25 April 2001 [6].
Poročilo tega odbora je bilo formalno sprejeto 25. aprila 2001 [6].
The Committee was asked to comment on the relevance of the metabolite IPSN due to its presence in soil and water.
Odbor je bil zaprošen za komentar o pomenu metabolita IPSN zaradi njegove prisotnosti v zemlji in vodi.
In its opinion the Committee concluded that there is no significant health risk arising from IPSN in the groundwater, and that the risk to soil micro-organisms, aquatic invertebrates, fish and the acute risk to earthworms are sufficiently addressed.
V svojem mnenju je Odbor zaključil, da ni pomembnega tveganja za zdravje zaradi nahajanja IPSN v podtalnici in da je predvideno tveganje za mikroorganizme v zemlji, vodne nevretenčarje, ribe in akutno tveganje za deževnike zadostno obravnavano.
The Committee also concluded that on the basis of worst-case exposure estimates further information is required to assess some other risks from IPSN.
Odbor je tudi zaključil, da so na podlagi ocen o izpostavljenosti v najslabšem možnem primeru potrebne nadaljnje informacije za oceno nekaterih drugih tveganj zaradi IPSN.
The Committee finally concluded that the risk to the environment and the toxicological risk to human health from the parent substance and/or metabolites other than IPSN, in some studies formed at levels comparable to IPSN, have not been fully assessed and therefore should be addressed during the further evaluation.
Odbor je nazadnje zaključil, da tveganje za okolje in toksikološko tveganje za zdravje ljudi zaradi osnovne aktivne snovi in/ali drugih metabolitov razen IPSN, v nekaterih študijah, narejenih na ravneh, primerljivih z IPSN, ni bilo v celoti ocenjeno in je zato treba to tveganje oceniti v nadaljnjem ocenjevanju.
With respect to IPSN, additional data on the risk based on worst-case exposure estimates and identified by the Scientific Committee have been delivered by the notifier and assessed.
Glede IPSN je prijavitelj posredoval dodatne podatke o tveganju, ki temelji na ocenah o izpostavljenosti v najslabšem možnem primeru in na katere je opozoril Znanstveni odbor, ti podatki so bili ocenjeni.
The evaluation within the Standing Committee concluded that in the light of the additional data submitted by the notifier, and under the proposed conditions of use, there would be no harmful effect on humans from IPSN.
V oceni, ki jo je dal Stalni odbor, je bilo sklenjeno, da glede na dodatne podatke, ki jih je predložil prijavitelj, in v okviru predlaganih pogojev uporabe, ISPN ne bo imel škodljivih učinkov na ljudi.
With respect to imazosulfuron and other metabolites than IPSN, no other metabolites than IPSN occur in levels that are considered as ‘relevant’ in the sense of the provisions of Directive 91/414/EEC.
V zvezi z imazosulfuronom in drugimi metaboliti, razen IPSN, se noben drug metabolit razen IPSN ne pojavlja v vrednostih, ki se štejejo za „pomembne“ v smislu določb Direktive 91/414/EGS.
Therefore the evaluation within the Standing Committee concluded that the risk can be assessed with the data available.
Zato je bilo v oceni Stalnega odbora zaključeno, da se tveganje lahko oceni na osnovi razpoložljivih podatkov.
Following this assessment, the evaluation within the Standing Committee furthermore concluded that under the proposed conditions of use, in particular the maximum dose rate of 0,05 kg active substance/ha, and when appropriate risk mitigation measures are applied, there would be no harmful effect on humans and no unacceptable risk to the environment from imazosulfuron and its metabolites.
Po tej ocenitvi je Stalni odbor v svoji oceni poleg tega zaključil, da v skladu s predlaganimi pogoji uporabe, zlasti glede najvišjega odmerka 0,05 kg aktivne snovi/ha, in kadar se uporabijo ustrezni ukrepi za zmanjšanje tveganja, imazosulfuron in njegovi metaboliti ne bodo imeli škodljivih učinkov na ljudi in ne nesprejemljivega vpliva na okolje.
The review of laminarin, methoxyfenozide and s-metolachlor did not reveal any open questions or concerns, which would have required a consultation of the Scientific Committee on Plants or of the European Food Safety Authority.
Med pregledom laminarina, metoksifenozida in s-metolaklora niso našli nobenih odprtih vprašanj ali vzrokov za zaskrbljenost, ki bi zahtevali posvetovanje z Znanstvenim odborom za rastline ali Evropsko agencijo za varno hrano.
It has appeared from the various examinations made that plant protection products containing the active substances concerned may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) and Article 5(3) of Directive 91/414/EEC, in particular with regard to the uses which were examined and detailed in the Commission review report.
Različne opravljene preiskave so pokazale, da je za fitofarmacevtska sredstva, ki vsebujejo katero koli od zadevnih aktivnih snovi, možno pričakovati, da na splošno izpolnjujejo zahteve iz člena 5(1)(a) in (b) in člena 5(3) Direktive 91/414/EGS, zlasti v zvezi z uporabami, ki so bile preučene in podrobno navedene v poročilih Komisije o pregledu.
It is therefore appropriate to include imazosulfuron, laminarin, methoxyfenozide and s-metolachlor in Annex I, in order to ensure that in all Member States the authorisations of plant protection products containing these active substances may be granted in accordance with the provisions of that Directive.
Primerno je torej vključiti imazosulfuron, laminarin, metoksifenozid in s-metolaklor v Prilogo I zato, da se lahko v vseh državah članicah odobri registracija fitofarmacevtskih sredstev, ki vsebujejo te aktivne snovi, v skladu z določbami navedene direktive.
After inclusion of imazosulfuron, laminarin, methoxyfenozide and s-metolachlor in Annex I to Directive 91/414/EEC, Member States should be allowed a reasonable period to implement the provisions of Directive 91/414/EEC as regards plant protection products containing those substances and in particular to review existing provisional authorisations and, by the end of this period at the latest, to transform those authorisations into full authorisations, to amend them or to withdraw them in accordance with the provisions of Directive 91/414/EEC.
Po vključitvi imazosulfurona, laminarina, metoksifenozida in s-metolaklora v Prilogo I k Direktivi 91/414/EGS je treba določiti ustrezen rok zato, da se državam članicam omogoči izvajanje določb Direktive 91/414/EGS o fitofarmacevtskih sredstvih, ki vsebujejo navedene snovi, ter zlasti pregledati obstoječe začasne registracije in najpozneje do izteka tega roka spremeniti te registracije v dokončne registracije, jih spremeniti ali umakniti v skladu z določbami Direktive 91/414/EGS.
It is therefore appropriate to amend Directive 91/414/EEC accordingly.
Zaradi tega je primerno ustrezno spremeniti Direktivo 91/414/EGS.
Member States shall adopt and publish by 30 September 2005 at the latest the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice sprejmejo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 30. septembra 2005.
They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.
Komisiji takoj sporočijo besedilo teh določb in korelacijsko tabelo med navedenimi določbami in to direktivo.
They shall apply those provisions from 1 October 2005.
Navedene določbe se uporabljajo od 1. oktobra 2005.
Member States shall review the authorisation for each plant protection product containing imazosulfuron, laminarin, methoxyfenozide or s-metolachlor to ensure that the conditions relating to this active substance set out in Annex I to Directive 91/414/EEC are complied with.
Države članice pregledajo registracijo za vsako fitofarmacevtsko sredstvo, ki vsebuje imazosulfuron, laminarin, metoksifenozid ali s-metolaklor, da zagotovijo izpolnjevanje pogojev v zvezi s to aktivno snovjo, določeno v Prilogi I k Direktivi 91/414/EGS.
Where necessary, they shall amend or withdraw authorisations in accordance with Directive 91/414/EEC by 30 September 2005 at the latest.
Po potrebi prilagodijo ali umaknejo registracije v skladu z Direktivo 91/414/EGS najpozneje do 30. septembra 2005.